awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q24644083-B1A459E4-6FC9-41D0-83A0-B3F4A933E929
Q24644083-B1A459E4-6FC9-41D0-83A0-B3F4A933E929
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24644083-B1A459E4-6FC9-41D0-83A0-B3F4A933E929
Bispecific antibodies for cancer therapy: the light at the end of the tunnel?
P2860
Q24644083-B1A459E4-6FC9-41D0-83A0-B3F4A933E929
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24644083-B1A459E4-6FC9-41D0-83A0-B3F4A933E929
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8a967fa28f433f03c038ad14feab6c2cf170208b
P2860
The trifunctional antibody ertumaxomab destroys tumor cells that express low levels of human epidermal growth factor receptor 2.